The management of Hodgkin's disease: Half a century of change

Annals of Oncology

Volumn 7, Issue 6, 1996, Pages 555-560

  Rosenberg, S A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Combined modality therapy; End results; Hodgkin's disease; Radiotherapy

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ARTICLE; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029844258     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010670     Document Type: Article

References (14)

1. Rosenberg SA. Henry S. Kaplan, 1918-1984: Obituary. Cancer Res 1984; 44: 2739.
2. Rosenberg SA, Kaplan HS. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 1985; 11: 5-22.
3. Lukes RJ, Craver LF, Hall TC et al. Report of the nomenclature committee. Cancer Res 1966; 26: 1311.
4. Pinkus G, Said J. Hodgkin's disease, lymphocyte predominance type, nodular - further evidence for a B-cell derivation: L&H variants of Reed-Sternberg cells express L26, a pan B-cell marker. Am J Pathol 1988; 133: 211-7.
5. Regula DP Jr, Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988; 318: 214-9.
6. Sundeen J, Cossman J, Jaffe E. Lymphocyte predominant Hodgkin's disease, nodular subtype with coexistent 'large cell lymphoma'. Histological progression or composite malignancy? Am J Surg Pathol 1988; 12: 599-606.
7. Hansmann M, Stein H, Fellbaum C et al. Nodular paragranuloma can transform into high-grade malignant lymphoma of B-type. Hum Pathol 1989; 20: 1169-75.
8. Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1.
9. Hagemeister FB, Fesus SM, Lamki LM et al. Role of the Gallium scan in Hodgkin's disease. Cancer 1990; 65: 1090-6.
10. Donaldson SS. Hodgkin's disease in children. Semin Oncol 1990; 17: 36-48.
11. Tucker MA, Coleman CN, Cox RS et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
12. Bartlett NL, Rosenberg SA, Hoppe RT et al. Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky and advanced Hodgkin's disease: A preliminary report. J Clin Oncol 1995; 13: 1080-8.
13. Klasa RJ, Connors JM, Fairey R et al. Treatment of early stage Hodgkin's disease: Improved outcome with brief chemotherapy and radiotherapy without staging laparotomy. Ann Oncol 1996; in press.
14. Radford JA, Cowan RA, Ryder WDJ et al. Four weeks of neoadjuvant chemotherapy significantly reduces the progression rate in patients treated with limited field radiotherapy for clinical stage (CS) IA/IIA Hodgkin's disease. Results of a randomized pilot study. Ann Oncol 1996; submitted.